RG-2833
| CAS No. | 1215493-56-3 |
|---|---|
| MDL No. | MFCD25976845 |
| MF | C20H25N3O2 |
| MW | 339.40 |
| InChI Key | VOPDXHFYDJAYNS-UHFFFAOYSA-N |
| CAS No. | 1215493-56-3 |
|---|---|
| MDL No. | MFCD25976845 |
| MF | C20H25N3O2 |
| MW | 339.40 |
| InChI Key | VOPDXHFYDJAYNS-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
RG-2833 is a secondary carboxamide formed by the condensation of the carboxy group of 4-methylbenzoic acid with the primary amino group of 6-amino-N-(2-aminophenyl)hexanamide. It is a HDAC1/HDAC3 inhibitor with brain penetration, acting as an antineoplastic agent, histone deacetylase inhibitor (EC 3.5.1.98), and nootropic. It is an anilide, secondary carboxamide, benzamide, toluene derivative, and substituted aniline, functionally related to 6-aminohexanoic acid.
| CAS No. | 1215493-56-3 |
|---|---|
| Product Name | RG-2833 |
| Heavy Atom Count | 25 | Rotatable Bond Count | 8 |
| Atom Stereo Count | 0 | Bond Stereo Count | 0 |
| HBA | 3 | HBD | 3 |
| TPSA | 84.220 Ų | Charge | 0 |
| Exact Mass | 339.19468 | Complexity | 711.14 |
| pKa | 7.130 | XLogP | 3.506 |